Aggressive B cell lymphomas—highlights from ASH 2022
Crossref DOI link: https://doi.org/10.1007/s12254-023-00908-y
Published Online: 2023-08-02
Published Print: 2023-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Panny, Michael
Text and Data Mining valid from 2023-08-02
Version of Record valid from 2023-08-02
Article History
Received: 15 May 2023
Accepted: 24 July 2023
First Online: 2 August 2023
Conflict of interest
: M. Panny has received honoraria from Roche and Abbvie.